A new review of published studies argues that the trace mineral chromium picolinate may have an edge over other popular weight management ingredients because it helps users preserve lean body mass.
After several years of being “overlooked” as fad ingredients took the spotlight, industry attention is returning to chromium picolinate, an ingredient with dozens of clinical trials to substantiate its benefits across a range of health conditions, says...
Supplements of chromium picolinate may help to control blood sugar levels in people with poorly controlled type 2 diabetes, says a new study from Brazil.
Nutrition 21 LLC and JDS Therapeutics LLC have entered into a confidential settlement and license agreement with Schwabe North America and Nature’s Way, thereby ending a patent infringement lawsuit involving the use of chromium picolinate.
The market for chromium is growing, driven by the ongoing tide of obesity and diabetes, said Bill Levi of Nutrition 21, which supplies Chromax, a patented form of chromium picolinate.
California-based InterHealth Nutraceuticals Inc has self-affirmed the Generally Recognized as Safe (GRAS) status of its next generation Zychrome chromium ingredient for use in food and beverages.
Daily supplements of InterHealth’s Zychrome chromium dinicocysteinate product may improve insulin management measures and outperform established chromium picolinate supplements, says a new study.
InterHealth Nutraceuticals Inc has launched a new chromium-based ingredient for maintaining normal insulin and blood sugar levels that will ‘reinvigorate the chromium market’, says the company’s CEO.
New York supplement company Nutrition 21 has received a warning
that it could face delisting from Nasdaq if its share price does
not regain the $1 minimum over the next 180 days.
Nutrition 21 is publicizing new clinical data indicating a
positive effect of chromium picolinate on cognitive function,
the results of which look set to expand the functional profile of
the ingredient.
A study from the Ohio State University Department of Human
Nutrition found that Nutrition 21's branded chromium picolinate is
absorbed better than other forms of the mineral linked to diabetes
benefits.
Nutrition 21 has reported significant operating losses in its
second quarter after bolstering marketing expenses to support its
shift into finished products – an effort it said has paid off in
increased sales.
Chromium picolinate as a nutritional supplement for diabetics does
have a significant positive effect on blood sugar, insulin, and
cholesterol levels, says a new review.
A daily supplement of chromium picolinate and biotin improved
glucose tolerance by 15 per cent, compared to placebo, says a new
study from Yale University.
Nutrition 21 has reported sales on a par with last year in full
year 2006 and increased losses, but believes it is on the cusp of
great things for the coming year as it fully implements its shift
from ingredients to finished products...
A daily supplement of chromium picolinate, in combination with a
common anti-diabetic medication, could improve blood sugar levels
as well as cutting weight gain by 60 per cent, says a US clinical
trial.
Nutrition 21 has high hopes for the distribution of its Chromax
chromium picolinate in retail outlets, with a major marketing
planned for the summer, but the first fruit of commercialization is
yet to be seen in its financial results.
Researchers have reported how chromium picolinate improves muscle
sensitivity to insulin in obese, insulin-resistant rats - findings
that could have implications for diabetic humans.
Nutrition 21 has announced that is Chromax chromium picolinate will
make its first appearance on retail shelves, following the receipt
of a purchase order from Rite Aid.
Nutrition 21's chromium picolinate ingredient, Chromax, is to be
used in a fiber product for the first time thanks to a new supply
and licensing agreement the company has carved out with CNS.
The FDA has issued a favorable response to a qualified health claim
petition filed by Nutrition 21 for the nutritional supplement
chromium picolinate, though it concluded that any link between
chromium picolinate and either insulin...
Low levels of the mineral chromium have been linked to an increased
risk of heart attack in men, offering further support for
nutrient's role in heart health, writes Dominique Patton.
Nutrition 21 is seeking to protect its store of intellectual
property by filing a lawsuit against GNC over its alleged
infringement of three of its chromium picolinate patents,
reports Jess Halliday.
A new animal study found that Nutrition 21's Chromax did not cause
genetic damage in hamster ovary cells, providing further evidence
for the safety of the company's chromium picolinate dietary
supplement and enabling its...
The FDA has requested an extension in its review of yet another
health claims petition, for Nutrition 21's submission linking
chromium picolinate with a reduced risk of insulin resistance, type
2 diabetes and related disease,...
Nutrition 21 is positioning Chromax as a food and beverage
additive, following the use of its proprietary chromium picolinate
ingredient in niche products marketed by Pepsi and Pharmavite.
US firm Nutrition 21 will seek to boost sales of chromium
piocolinate in Europe, following acceptance of a scientific dossier
in the UK that gives the ingredient up to four years of derogation
from the food supplements directive,...
The first clinical trial into the effects of chromium
supplementation in children with type 1 diabetes is now underway at
the Childrens' Hospital in Los Angeles, announced Nutrition 21,
which is supplying Chromax chromium picolinate...
The maker of chromium-based supplements has reported a 12.6 percent
sales increase for the quarter ended 31 December 2004, up to $2.6
million compared with $2.3 million for the same period of last
year.
Nutrition 21 said recently that the NIH would continue to fund
research into the benefits of chromium picolinate for sufferes of
diabetes. The company's CEO told NutraIngredientsUSA.com what this
means and her company's...
Nutrition 21 announced last week that a bill signed into law by
President George Bush recognizes the health benefits of chromium
picolinate towards diabetes and urges further research into its
capabilities.
Nutrition 21, specialising in chromium-based nutritional
supplements, almost halved losses in the three months to December
as it shed costs associated with its discontinued Lite-Bites
business and achieved higher pricing for its core...
Supplement manufacturer Nutrition 21 has filed a health claim
petition with the US Food and Drug Administration (FDA) for use of
eight dietary supplement health claims associating chromium
picolinate supplementation with reduced risk...
Daily supplementation with 1,000 mcg of chromium as chromium
picolinate could be used as a new nutritional therapy for
polycystic ovarian syndrome, according to results of a new pilot
study funded by the National Institutes of Health.
Chromium picolinate supplier Nutrition 21 has filed for a partial
summary judgment on its suit against InterHealth Nutraceuticals,
which it alleges uses misleading advertising for its chromium
products.
Further independent research suggests that daily nutritional
supplementation with 1,000 mcg of chromium as chromium picolinate
can significantly decrease blood sugar levels in insulin-treated
people with poorly-controlled type 2 diabetes.
A supplement containing chromium picolinate and biotin
significantly reduced elevated blood sugar levels in people with
type 2 diabetes after only twelve weeks, reported researchers at
the International Diabetes Federation (IDF) Congress...
Chromium picolinate manufacturer Nutrition 21 reports on new
studies including a combination of chromium picolinate and CLA
found to increase muscle glycogen levels, contributing to physical
strength and endurance.
Chromium supplement maker Nutrition 21 last week reported a net
loss of $1.1 million on revenues of $3.1 million for the third
quarter, compared with a loss of $0.2 million on revenues of $4.0
million for the same period a year ago.
The dietary supplement industry has responded to last week's report
from an expert group in the UK which recommends new, "conservative"
upper safe levels for vitamins and minerals, and also advises a ban
on chromium...
A recent conference on chromium picolinate highlighted the evidence
backing the use of chromium in glucose control for people with type
2 diabetes and insulin resistance, suggests chromium maker
Nutrition 21.
Nutrition 21, the US producer of chromium picolinate products, has
announced that it will provide data to the US Institute of Medicine
(IOM) to help it assess the safety of the product.
